Director Shareholding

| Filed in:
Tate & Lyle PLC (the Company) was informed on 5 November 2004 that the following share transactions were completed by Directors of the Company: On 5 November 2004, Mr Simon Gifford, an Executive Director of the Company, sold 6,000 ordinary shares of the Company at 451 pence per share. Mr Gifford now has an interest in 75,014 ordinary shares in the Company. On 5 November 2004, Mr Stanley Musesengwa, an Executive Director of the Company, exercised the following options over ordinary shares of the Company under the Tate & Lyle 1992 Executive Share Option Scheme: 13,000 options at 425 pence per share 26,785 options at 336 pence per share 70,437 options at 274 pence per share He subsequently sold 89,253 ordinary shares at 456.50 pence per share to pay the subscription price, tax and National Insurance, and retained 20,969 ordinary shares. Following this transaction, Mr Musesengwa now has an interest in 26,969 ordinary shares in the Company.

About Tate & Lyle:
Tate & Lyle is a global provider of ingredients and solutions to the food, beverage and other industries, with operations in over 30 locations worldwide.

Tate & Lyle operates through two global divisions, Speciality Food Ingredients and Bulk Ingredients, supported by our Innovation and Commercial Development and Global Operations groups. The Group's strategy is to become a leading global provider of Speciality Food Ingredients through a disciplined focus on growth, and by driving Bulk Ingredients for sustained cash generation to fuel this growth.

Speciality Food Ingredients consists of three platforms: Texturants, which includes speciality starches and stabilisers; Sweeteners, which comprises nutritive sweeteners and our range of no-calorie sweeteners including SPLENDA® Sucralose; and our Health and Wellness portfolio which includes speciality fibres and our salt-reduction offering. Additionally, our Food Systems business provides a wide variety of blended ingredient solutions.

Tate & Lyle Bulk Ingredients includes bulk sweeteners, industrial starches and fermentation products (primarily acidulants). Corn co-products from both divisions are primarily sold as animal feed.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2017, Tate & Lyle sales totalled £2.8 billion. For more information, please visit

SPLENDA® is a trademark of Heartland Consumer Products LLC.